GRP
KYMR icon

Global Retirement Partners’s Kymera Therapeutics KYMR Stock Holding History

Global Retirement Partners’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.41K Buy
+21
New +$1.8K ﹤0.01% 3941
2025
Q4 		$1.17K Buy
+15
New +$1.01K ﹤0.01% 3859

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Global Retirement Partners's KYMR Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Kymera Therapeutics (KYMR) in Q2 2026: 21 shares worth $2.41K. The stake represents ﹤0.01% of the portfolio and ranks #3941 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in KYMR as recently as Q4 2025.

Global Retirement Partners first reported a position in KYMR in Q4 2025 and has held it in 2 quarters since. 276 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Global Retirement Partners held 21 shares of Kymera Therapeutics worth $2.41K as of Q2 2026.
  • Kymera Therapeutics was a new Global Retirement Partners position in Q2 2026.
  • Kymera Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #3941 holding.
  • Global Retirement Partners first reported a position in Kymera Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 276 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.